Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.
Autorzy:
Miller ET; Department of Urology, David Geffen School of Medicine at UCLA, Box 951738, 10833 Le Conte Ave 66-188 CHS UCLA, Los Angeles, CA, 90095, USA. You S; Department of Biomedical Sciences, Cedars-Sinai Medical Center, California, Los Angeles, USA. Cadaneanu RM; Department of Urology, David Geffen School of Medicine at UCLA, Box 951738, 10833 Le Conte Ave 66-188 CHS UCLA, Los Angeles, CA, 90095, USA. Kim M; Department of Surgery, Cedars-Sinai Medical Center, California, Los Angeles, USA. Yoon J; Department of Surgery, Cedars-Sinai Medical Center, California, Los Angeles, USA. Liu ST; Department of Urology, David Geffen School of Medicine at UCLA, Box 951738, 10833 Le Conte Ave 66-188 CHS UCLA, Los Angeles, CA, 90095, USA.; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at UCLA, California, Los Angeles, USA. Li X; Department of Pathology, David Geffen School of Medicine at UCLA, California, Los Angeles, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Box 951738, 10833 Le Conte Ave 66-188 CHS UCLA, Los Angeles, CA, 90095, USA. Kwan L; Department of Urology, David Geffen School of Medicine at UCLA, Box 951738, 10833 Le Conte Ave 66-188 CHS UCLA, Los Angeles, CA, 90095, USA. Hodge J; Department of Biomedical Sciences, Cedars-Sinai Medical Center, California, Los Angeles, USA. QuistMJ; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at UCLA, California, Los Angeles, USA. Grasso CS; Department of Surgery, Cedars-Sinai Medical Center, California, Los Angeles, USA. Lewis MS; Department of Pathology, Greater Los Angeles Veterans Affairs Health System, California, Los Angeles, USA. Knudsen BS; Department of Biomedical Sciences, Cedars-Sinai Medical Center, California, Los Angeles, USA. Freeman MR; Department of Biomedical Sciences, Cedars-Sinai Medical Center, California, Los Angeles, USA. Garraway IP; Department of Urology, David Geffen School of Medicine at UCLA, Box 951738, 10833 Le Conte Ave 66-188 CHS UCLA, Los Angeles, CA, 90095, USA. .; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Box 951738, 10833 Le Conte Ave 66-188 CHS UCLA, Los Angeles, CA, 90095, USA. .; Division of Urology, Greater Los Angeles Veterans Affairs Healthcare Center, Box 951738, 10833 Le Conte Ave 66-188 CHS UCLA, Los Angeles, CA, 90095, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 May 07; Vol. 20 (1), pp. 398. Date of Electronic Publication: 2020 May 07.
Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma.
Autorzy:
Berlow NE; Children's Cancer Therapy Development Institute, Beaverton, OR 97005, USA.; Electrical and Computer Engineering, Texas Tech University, Lubbock, TX 79409, USA.; Division of Hematology-Oncology, University of California, Los Angeles, CA 90095, USA. Grasso CS; Division of Hematology-Oncology, University of California, Los Angeles, CA 90095, USA. QuistMJ; Division of Hematology-Oncology, University of California, Los Angeles, CA 90095, USA. Cheng M; The Jackson Laboratory, Bar Harbor, ME 04609, USA. Gandour-Edwards R; Department of Pathology & Laboratory Medicine, UC Davis Health System, Sacramento, CA 95817, USA. Hernandez BS; Department of Epidemiology and Biostatistics, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA. Michalek JE; Department of Epidemiology and Biostatistics, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA. Ryan C; School of Medicine, Oregon Health and Science University, Portland, OR 97239, USA. Spellman P; School of Medicine, Oregon Health and Science University, Portland, OR 97239, USA. Pal R; Electrical and Computer Engineering, Texas Tech University, Lubbock, TX 79409, USA. Million LS; Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA. Renneker M; Patient-Directed Consultations, San Francisco, CA 94116, USA.; Department of Family Medicine, University of California San Francisco, San Francisco, CA 94143, USA. Keller C; Children's Cancer Therapy Development Institute, Beaverton, OR 97005, USA.; Electrical and Computer Engineering, Texas Tech University, Lubbock, TX 79409, USA.
Pokaż więcej
Źródło:
Sarcoma [Sarcoma] 2020 May 04; Vol. 2020, pp. 6312480. Date of Electronic Publication: 2020 May 04 (Print Publication: 2020).
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.
Autorzy:
Berlow NE; Children's Cancer Therapy Development Institute, 12655 SW Beaverdam Road-West, Beaverton, OR, 97005, USA. .; Electrical and Computer Engineering, Texas Tech University, Lubbock, TX, 79409, USA. . Rikhi R; Children's Cancer Therapy Development Institute, 12655 SW Beaverdam Road-West, Beaverton, OR, 97005, USA. Geltzeiler M; Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.; Department of Otolaryngology - Head and Neck Surgery, Oregon Health & Science University, Portland, OR, 97239, USA. Abraham J; Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA. Svalina MN; Children's Cancer Therapy Development Institute, 12655 SW Beaverdam Road-West, Beaverton, OR, 97005, USA. Davis LE; Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA. Wise E; Champions Oncology, Baltimore, MD, 21205, USA. Mancini M; Champions Oncology, Baltimore, MD, 21205, USA. Noujaim J; Royal Marsden Hospital and Institute of Cancer Research, London, SW3 6JJ, UK.; Hôpital Maisonneuve-Rosemont, Montreal, H1T 2M4, Canada. Mansoor A; Department of Pathology, Oregon Health & Science University, Portland, OR, 97239, USA. QuistMJ; Center for Spatial Systems Biomedicine Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, 97239, USA. Matlock KL; Electrical and Computer Engineering, Texas Tech University, Lubbock, TX, 79409, USA.; Omics Data Automation, 12655 SW Beaverdam Road, Beaverton, OR 97005, USA. Goros MW; Department of Epidemiology and Biostatistics, University of Texas Health Science Center San Antonio, San Antonio, TX, 78229, USA. Hernandez BS; Department of Epidemiology and Biostatistics, University of Texas Health Science Center San Antonio, San Antonio, TX, 78229, USA. Doung YC; Department of Orthopedic Surgery, Oregon Health & Science University, Portland, OR, 97239, USA. Thway K; Royal Marsden Hospital and Institute of Cancer Research, London, SW3 6JJ, UK. Tsukahara T; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan. Nishio J; Department of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, 814-0180, Japan. Huang ET; Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA. Airhart S; The Jackson Laboratory, Bar Harbor, ME, 04609, USA. Bult CJ; The Jackson Laboratory, Bar Harbor, ME, 04609, USA. Gandour-Edwards R; Department of Pathology & Laboratory Medicine, UC Davis Health System, Sacramento, CA, 95817, USA. Maki RG; Sarcoma Program, Zucker School of Medicine at Hofstra/Northwell & Cold Spring Harbor Laboratory, Long Island, NY, 10142, USA. Jones RL; Royal Marsden Hospital and Institute of Cancer Research, London, SW3 6JJ, UK. Michalek JE; Department of Epidemiology and Biostatistics, University of Texas Health Science Center San Antonio, San Antonio, TX, 78229, USA. Milovancev M; Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, 97331, USA. Ghosh S; Department of Mathematics and Statistics, Texas Tech University, Lubbock, TX, 79409, USA. Pal R; Electrical and Computer Engineering, Texas Tech University, Lubbock, TX, 79409, USA. . Keller C; Children's Cancer Therapy Development Institute, 12655 SW Beaverdam Road-West, Beaverton, OR, 97005, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2019 Jun 17; Vol. 19 (1), pp. 593. Date of Electronic Publication: 2019 Jun 17.
IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma.
Autorzy:
Berlow NE; Children's Cancer Therapy Development Institute, Beaverton, OR, United States of America. Svalina MN; Children's Cancer Therapy Development Institute, Beaverton, OR, United States of America. QuistMJ; Children's Cancer Therapy Development Institute, Beaverton, OR, United States of America. Settelmeyer TP; Children's Cancer Therapy Development Institute, Beaverton, OR, United States of America. Zherebitskiy V; Department of Pathology, Oregon Health & Science University, Portland, OR, United States of America. Kogiso M; Department of Pediatrics, Texas Children's Cancer Center, Houston, TX, United States of America. Qi L; Department of Pediatrics, Texas Children's Cancer Center, Houston, TX, United States of America. Du Y; Department of Pediatrics, Texas Children's Cancer Center, Houston, TX, United States of America. Hawkins CE; Division of Pathology, The Hospital for Sick Children, Toronto, ON, CANADA. Hulleman E; Neuro-Oncology Research Group, Cancer Center Amsterdam, Vrije Universiteit University Medical Center, Amsterdam, The Netherlands. Li XN; Department of Pediatrics, Texas Children's Cancer Center, Houston, TX, United States of America. Gultekin SH; Department of Pathology, Oregon Health & Science University, Portland, OR, United States of America. Keller C; Children's Cancer Therapy Development Institute, Beaverton, OR, United States of America.; Department of Pediatrics, Oregon Health & Science University, Portland, OR, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Apr 05; Vol. 13 (4), pp. e0193565. Date of Electronic Publication: 2018 Apr 05 (Print Publication: 2018).
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.
Autorzy:
Grasso CS; Center for Spatial Systems Biomedicine, Department of Molecular and Medical Genetics, Oregon Health &Science University (OHSU), Portland, Oregon, USA. Tang Y; 1] Department of Neurology, Stanford University, Stanford, California, USA. [2] Department of Neurosurgery, Stanford University, Stanford, California, USA. [3] Department of Pediatrics, Stanford University, Stanford, California, USA. [4] Department of Pathology, Stanford University, Stanford, California, USA. [5] Present addresses: Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Y.T.) and Department of Neurosurgery, The First Affiliated Hospital of Suzhou University, Suzhou, China (Y.H.). Truffaux N; CNRS, UMR 8203, Gustave Roussy, Université Paris-Sud, Villejuif, France. Berlow NE; Electrical and Computer Engineering, Texas Tech University, Lubbock, Texas, USA. Liu L; 1] Department of Neurology, Stanford University, Stanford, California, USA. [2] Department of Neurosurgery, Stanford University, Stanford, California, USA. [3] Department of Pediatrics, Stanford University, Stanford, California, USA. [4] Department of Pathology, Stanford University, Stanford, California, USA. Debily MA; 1] CNRS, UMR 8203, Gustave Roussy, Université Paris-Sud, Villejuif, France. [2] Département de biologie, Université d'Evry-Val d'Essone, Evry, France. QuistMJ; Center for Spatial Systems Biomedicine, Department of Molecular and Medical Genetics, Oregon Health &Science University (OHSU), Portland, Oregon, USA. Davis LE; Pediatric Cancer Biology Program, Papé Family Pediatric Research Institute, Department of Pediatrics, OHSU, Portland, Oregon, USA. Huang EC; Pediatric Cancer Biology Program, Papé Family Pediatric Research Institute, Department of Pediatrics, OHSU, Portland, Oregon, USA. Woo PJ; 1] Department of Neurology, Stanford University, Stanford, California, USA. [2] Department of Neurosurgery, Stanford University, Stanford, California, USA. [3] Department of Pediatrics, Stanford University, Stanford, California, USA. [4] Department of Pathology, Stanford University, Stanford, California, USA. Ponnuswami A; 1] Department of Neurology, Stanford University, Stanford, California, USA. [2] Department of Neurosurgery, Stanford University, Stanford, California, USA. [3] Department of Pediatrics, Stanford University, Stanford, California, USA. [4] Department of Pathology, Stanford University, Stanford, California, USA. Chen S; 1] Department of Neurology, Stanford University, Stanford, California, USA. [2] Department of Neurosurgery, Stanford University, Stanford, California, USA. [3] Department of Pediatrics, Stanford University, Stanford, California, USA. [4] Department of Pathology, Stanford University, Stanford, California, USA. Johung TB; 1] Department of Neurology, Stanford University, Stanford, California, USA. [2] Department of Neurosurgery, Stanford University, Stanford, California, USA. [3] Department of Pediatrics, Stanford University, Stanford, California, USA. [4] Department of Pathology, Stanford University, Stanford, California, USA. Sun W; Department of Neurology, Stanford University, Stanford, California, USA. Kogiso M; Laboratory of Molecular Neurooncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA. Du Y; Laboratory of Molecular Neurooncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA. Qi L; Laboratory of Molecular Neurooncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA. Huang Y; 1] Laboratory of Molecular Neurooncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA. [2] Present addresses: Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Y.T.) and Department of Neurosurgery, The First Affiliated Hospital of Suzhou University, Suzhou, China (Y.H.). Hütt-Cabezas M; 1] Department of Oncology, Johns Hopkins University, Baltimore, Maryland, USA. [2] Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA. Warren KE; National Cancer Institute, Bethesda, Maryland, USA. Le Dret L; CNRS, UMR 8203, Gustave Roussy, Université Paris-Sud, Villejuif, France. Meltzer PS; National Cancer Institute, Bethesda, Maryland, USA. Mao H; Laboratory of Molecular Neurooncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA. Quezado M; National Cancer Institute, Bethesda, Maryland, USA. van Vuurden DG; 1] Department of Pediatric Oncology and Hematology, VU University Medical Center, Amsterdam, The Netherlands. [2] Neuro-Oncology Research Group Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands. Abraham J; Pediatric Cancer Biology Program, Papé Family Pediatric Research Institute, Department of Pediatrics, OHSU, Portland, Oregon, USA. Fouladi M; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Svalina MN; 1] Center for Spatial Systems Biomedicine, Department of Molecular and Medical Genetics, Oregon Health &Science University (OHSU), Portland, Oregon, USA. [2] Children's Cancer Therapy Development Institute, Fort Collins, Colorado, USA. Wang N; Center for Spatial Systems Biomedicine, Department of Molecular and Medical Genetics, Oregon Health &Science University (OHSU), Portland, Oregon, USA. Hawkins C; 1] Department of Pediatric Laboratory Medicine, University of Toronto, Toronto, Ontario, Canada. [2] Labatt Brain Tumor Research Centre, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. Nazarian J; Center for Research Institute, Children's National Health Systems, Washington, DC, USA. Alonso MM; Department of Oncology, University Hospital of Navarra, Pamplona, Spain. Raabe EH; 1] Department of Oncology, Johns Hopkins University, Baltimore, Maryland, USA. [2] Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA. Hulleman E; 1] Department of Pediatric Oncology and Hematology, VU University Medical Center, Amsterdam, The Netherlands. [2] Neuro-Oncology Research Group Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands. Spellman PT; Center for Spatial Systems Biomedicine, Department of Molecular and Medical Genetics, Oregon Health &Science University (OHSU), Portland, Oregon, USA. Li XN; Laboratory of Molecular Neurooncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA. Keller C; 1] Pediatric Cancer Biology Program, Papé Family Pediatric Research Institute, Department of Pediatrics, OHSU, Portland, Oregon, USA. [2] Children's Cancer Therapy Development Institute, Fort Collins, Colorado, USA. Pal R; Electrical and Computer Engineering, Texas Tech University, Lubbock, Texas, USA. Grill J; 1] CNRS, UMR 8203, Gustave Roussy, Université Paris-Sud, Villejuif, France. [2] Departement de Cancerologie de l'Enfant et de l'Adolescent, Institut Gustave Roussy, Université Paris-Sud, Villejuif, France. Monje M; 1] Department of Neurology, Stanford University, Stanford, California, USA. [2] Department of Neurosurgery, Stanford University, Stanford, California, USA. [3] Department of Pediatrics, Stanford University, Stanford, California, USA. [4] Department of Pathology, Stanford University, Stanford, California, USA.
Pokaż więcej
Źródło:
Nature medicine [Nat Med] 2015 Jun; Vol. 21 (6), pp. 555-9. Date of Electronic Publication: 2015 May 04.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
